Many studies reviewed in this paper suggest that myokine-induced AMPK signalling increases insulin sensitivity and glucose uptake to reduce hyperglycemia and counteract the effects of obesity and diabetes. The gene discussed is PRKAA2; the disease is obesity due to melanocortin 4 receptor deficiency.